| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911533 | Lung Cancer | 2005 | 8 Pages |
Abstract
The results of the present trial clearly demonstrates that TMZ is active and safe in BrM NSCLC patients previously treated with WBRT and at least one line of chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Carmelo Giannitto Giorgio, Dario Giuffrida, Alessandro Pappalardo, Antonio Russo, Daniele Santini, Placida Salice, Giusy Blanco, Sergio Castorina, Giuseppe Failla, Roberto Bordonaro,